Actor Samantha Ruth Prabhu has always been vocal about health and wellness. In a recent conversation with Dubai-based ...

Before Brenda Rogers started taking Ozempic in the spring of 2023, she didn't realize how much "food noise" was sapping her ...

The term "food noise" has emerged alongside the popularity of Ozempic and other GLP-1 receptor agonist medications. (Jan. 10, 2026) ...

Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving ...

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is one of the best performing pharma stocks in 2025. Amylyx Pharmaceuticals, Inc.

ATRIMED today shared an update on a long running research effort led in part by physician scientist Dr. Latha Damle, whose work alongside her husband and research partner, Dr. Damle, has helped build ...

Since its introduction by Polly Matzinger, the Danger Theory has profoundly reshaped modern immunology. Rather than relying solely on a self/non-self ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

Megestrol, which helps treat hot flashes associated with menopause, may have the added benefit of slowing the growth of ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...

Struggling with alcohol cravings? Naltrexone targets the brain's reward center to minimize drinking urges and reduce harmful ...

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...